Phase 4 Disorder Clinical Trials
161 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 161 trials
Recruiting
Phase 4
A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression
Depressive Disorder, Treatment-Resistant
Janssen Korea, Ltd., Korea47 enrolled6 locationsNCT07053345
Recruiting
Phase 4
CLOZAPINE Response in Biotype-1
SchizophreniaSchizoaffective DisorderBipolar 1 Disorder
University of Texas Southwestern Medical Center524 enrolled5 locationsNCT04580134
Recruiting
Phase 4
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
Disorder of ConsciousnessHemorrhagic Stroke
Konkuk University Medical Center12 enrolled1 locationNCT04427241
Recruiting
Phase 4
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
SchizophreniaMajor Depressive DisorderBipolar Disorder+2 more
Neurocrine Biosciences50 enrolled21 locationsNCT07105111
Recruiting
Phase 4
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder
Premenstrual Dysphoric Disorder (PMDD)
Johns Hopkins University288 enrolled2 locationsNCT06704594
Recruiting
Phase 4
Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With Propranolol: Effect on Psychophysiological Reactivity During Traumatic Imagery
Stress Disorders, Post-Traumatic
Massachusetts General Hospital80 enrolled1 locationNCT05853627
Recruiting
Phase 4
Aβ Dynamics in LLMD
Alzheimer DiseaseMajor Depressive Disorder
NYU Langone Health60 enrolled2 locationsNCT05004987
Recruiting
Phase 4
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
Opioid-use Disorder
Yale University600 enrolled6 locationsNCT06323824
Recruiting
Phase 4
Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial
Opioid-use Disorder
Pouya Azar12 enrolled2 locationsNCT07439549
Recruiting
Phase 4
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute280 enrolled7 locationsNCT05208190
Recruiting
Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
PreeclampsiaHypertensive Disorders of PregnancyGestational Hypertension
Ohio State University10,742 enrolled16 locationsNCT06468202
Recruiting
Phase 4
Beta-Adrenergic Modulation of Drug Cue Reactivity
Tobacco Use DisorderNicotine DependenceCigarette Smoking
University of Oklahoma80 enrolled1 locationNCT05587361
Recruiting
Phase 4
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
Major Depressive DisorderChronic Major Depression, Recurrent
University of Texas at Austin50 enrolled1 locationNCT05892744
Recruiting
Phase 4
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
Attention Deficit Hyperactivity Disorder
NYU Langone Health30 enrolled1 locationNCT06577779
Recruiting
Phase 4
Fluid Challenge and Plasma Volume, During Surgery
Colorectal, CancerGynecologic CancerUrologic Cancer+2 more
Joachim Zdolsek60 enrolled1 locationNCT05726136
Recruiting
Phase 4
Skin Preparation for Elective Foot and Ankle Surgery
Microbial ColonizationFoot and Ankle Disorders
University of Missouri-Columbia100 enrolled1 locationNCT05401292
Recruiting
Phase 4
Biomarkers to Enhance Early Schizophrenia Treatment
Schizophenia Disorder
Northwell Health180 enrolled2 locationsNCT06969755
Recruiting
Phase 4
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
SleepAlzheimer DiseaseInsomnia Disorder
University Hospital, Montpellier62 enrolled1 locationNCT05924425
Recruiting
Phase 4
SWIFT - SWIss Factor XIII Trial in PPH
Postpartum ComplicationCoagulation DisorderPostpartum Hemorrhage+2 more
Christian Haslinger988 enrolled9 locationsNCT06481995
Recruiting
Phase 4
Taper Or Abrupt Steroid Stop: TOASSTtrial
AutoimmuneInflammatory Disorder
University Hospital, Basel, Switzerland530 enrolled16 locationsNCT03153527